Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Bristol Goes In Big On New Valentine Nektar

Feb 14 2018

• By Jessica Merrill

Handshake of businessmen

Related Content

The Bang For Celgene’s Buck: Looking Inside The Record-Setting Juno Deal

Jul 13 2015

Nektar's IL-2 Impresses In Combination With Bristol's Opdivo

Nov 15 2017

Flexus flips IDO inhibitors to Bristol-Myers for up to $1.25bn

Feb 24 2015

Celgene Seeks CAR-T Leadership, Hematology Diversification With Juno Buy

Jan 23 2018

Bristol Debuts Opdivo/Yervoy Data In New First-Line Lung Cancer Bid

Feb 06 2018

A Whopper Of A Deal: AZ Hands Half Of Lynparza To Merck

Jul 27 2017

Related Companies

Bristol Myers Squibb Company

Nektar Therapeutics

Merck & Co., Inc.

AstraZeneca PLC

Bristol Myers Squibb Company

Bristol Myers Squibb Company

Bristol Myers Squibb Company

Additional Topics

Deals ImmunoOncology Business Strategies Research & Development Cancer BioPharmaceutical

More from Deals

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window